Radioiodine therapy oflung cancer following targeting expression of thesodium iodide symporter induced by midkine promoter
Conclusions: These results indicate that expression of NIS under control of the midkine promoter can likely be used to achieve cancer-specific expression of NIS in lung cancer. In combination with radioiodine therapy, this strategy is a possible method of lung cancer therapy.
Source: Journal of Nuclear Medicine - Category: Nuclear Medicine Authors: Mu, D. Tags: Basic Science Posters (Oncology) Source Type: research
More News: Adenoviruses | Cancer | Cancer & Oncology | Cancer Therapy | Genetics | Lung Cancer | Nuclear Medicine | Radioiodine Therapy | Science | Sodium